We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Byotrol Plc | LSE:BYOT | London | Ordinary Share | GB00B0999995 | ORDS 0.01P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.125 | 0.05 | 0.20 | 0.125 | 0.125 | 0.125 | 2,501,910 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Chemicals & Chem Preps, Nec | 4.59M | -1.69M | -0.0037 | -0.32 | 544.67k |
From Apr 2019 to Apr 2024
TIDMBYOT
RNS Number : 0342L
Byotrol PLC
03 September 2019
Byotrol plc
Notice of Results
Byotrol plc, the specialist anti-microbial technology company, announces that it will be releasing its audited results for the year ended 31 March 2019, no later than 27 September, 2019.
Enquiries:
David Traynor - Chief Executive, Byotrol plc 01925 742 000
Nic Hellyer - Chief Financial Officer, Byotrol plc
01925 742 000
finnCap Ltd 020 7220 0500 (Nominated Adviser & Broker)
Geoff Nash/Kate Bannatyne- Corporate Finance
Richard Chambers - Corporate Broking
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of antimicrobial technologies. Our patented suite of technologies deliver powerful broad-spectrum efficacy with long-lasting performance, optimised against commonly occurring and industry-specific pathogens.
Founded in 2005, the Company has developed advanced antimicrobial technologies that create easier, safer and cleaner lives for everyone.
For more information, please go to www.byotrol.co.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
NORUGUQUBUPBURW
(END) Dow Jones Newswires
September 03, 2019 04:08 ET (08:08 GMT)
1 Year Byotrol Chart |
1 Month Byotrol Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
